glp-1 + nad Multiple target tissue effects of analogues on non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) Introducing Thrive Forward Longevity Lifestyle

Common mistakes people make when weaning off Learning from the mistakes of others is cheaper than making them yourself

: ,

Evidence for Kidney Benefits Clinical trials show consistent kidney benefits: FLOW trial (semaglutide): This dedicated kidney outcome trial showed semaglutide reduced the risk of major kidney outcomes (kidney failure, significant decline in kidney function, or kidney-related death) by 24% in diabetic patients with chronic kidney disease

Turn ordinary foods into functional superfoods with GLP-1 Daily Support, a 4-in-1 prebiotic blend that naturally aids appetite control, blood sugar balance, and metabolic health

Weight management in type 2 diabetes: current and emerging approaches to treatment

The ability to directly and reliably measure circulating insulin levels led to the description that oral glucose administration results in considerably higher insulin responses when compared with intravenous glucose, heralding in a renewed interest in incretins